Skip to main content

Table 1 Events and timeline of the disease course in patient one in co-infection of HIV and SARS-CoV-2

From: New HIV diagnoses in patients with COVID-19: two case reports and a brief literature review

Hospitalization

Day1

Day2

Day3

Day4

Day5

Day6

Day7

Day8

Day9

Day10

Day11

Day12

Day13

Day14

Day15

Day16

Day17

Day18

Day19

Day20

Day21

Day22

Day23

Day24

Day25

Day26

Day27

Day28

Day29

Day49

Fever, °C

36.5

37

37

37

37

38.5

37.4

37.2

38

37

37.1

37.1

40

36.8

36.7

37

36.6

37

36.5

36.5

36.5

36.5

36.6

37

37.2

36.8

37.2

36.4

36.5

 

Nasopharyngeal swabs

          

N

         

N

N

        

WBC counts, ×109/L

 

6.3

     

5.0

     

6.9

   

4.3

     

7.8

      

Lymphocyte, × 109/L

 

1.08

     

1.16

     

1.20

   

0.70

     

1.31

      

Platelet, × 1012/L

 

285

     

273

     

272

   

249

     

210

      

CRP, mg/L

 

39.71

                     

0.29

      

Procalcitonin, ng/ml

 

0.03

               

0.01

     

0.02

      

Albumin, g/L

 

38.2

     

36.2

         

33.1

   

32.7

 

32.5

      

Interlukin-6, pg/mL

            

30.54

      

688.40

    

521.00

     

SARS-CoV-2 IgG

              

63.52

         

3.87

     

SARS-CoV-2 IgM

              

30.12

         

0.96

     

CD4 T cells/μL

                        

13

     

imaging findings

    

GGO

      

GGO,

       

GGO,

    

GGO,,some become solic

     

HIV viral load (copies/mL)

                             

1.7 × 105

  1. Abbreviations: COVID-19 Coronavirus disease 2019; CRP C-reactive protein; GGO Ground-glass opacities; HIV Human immunodeficiency virus; IgM Immunoglobulin M; WBC White blood cell; N Negative
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us